Narcan: The Nasal Spray Maker is Aiming for an Over-the-Counter-Price of Less than $50
Adapt Pharma, the maker of the life-saving opioid overdose reversal medication Narcan nasal spray, has announced plans to bring the product to over-the-counter (OTC) status with a price point of less than $50. Narcan, which contains naloxone, can quickly restore breathing in a person experiencing an opioid overdose and has been credited with saving countless lives since its approval by the U.S. Food and Drug Administration in 2015. Currently, it is available by prescription only and can cost upwards of $150 per dose, depending on insurance coverage. With the rise of opioid overdose deaths in recent years, there has been increased demand for the medication and a push for it to become more widely accessible. Making Narcan nasal spray available OTC could increase access for individuals who do not have a prescription or insurance coverage, as well as for family and friends of those at risk for opioid overdose. Adapt Pharma, which was acquired by Emergent BioSolutions in 2018, is wor...